Understanding Colorectal Cancer Screening: Methods and Recommendations- Part 1

corumoffpage 1 views 6 slides Oct 29, 2025
Slide 1
Slide 1 of 6
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6

About This Presentation

Colorectal cancer screening saves lives. For average-risk adults, screen ages 50–75; ages 76–85 need individualized decisions; routine screening isn’t advised after 86. High-risk people (family history, IBD, inherited syndromes) should start earlier and screen more often. Home options include ...


Slide Content

UNDERSTANDING COLORECTAL
CANCER SCREENING: METHODS AND
RECOMMENDATIONS

SCREENING RECOMMENDATIONS Screening recommended for adults aged 50–75 years
(average risk)
Ages 76–85: individualised screening based on health
and prior results
Ages 86+: routine screening not recommended
High-risk individuals (family history, IBD, inherited
syndromes):
Start earlier
Screen more frequently

FAECAL OCCULT BLOOD TEST (FOBT) Detects tiny amounts of blood in stool (hidden bleeding)
Two FDA-approved types:
Recommended annually if used alone
Reduces colorectal cancer deaths by 15–33% when
done every 1–2 years
Guaiac FOBT (gFOBT) – detects heme; requires dietary
restrictions
Faecal Immunochemical Test (FIT/iFOBT) – detects human
haemoglobin; no diet limits

STOOL DNA TEST (FIT-DNA) Combines FIT (blood detection) + DNA biomarkers
(from colon cells)
Detects mutations linked to colorectal cancer and
precancerous adenomas
Sample collected at home, mailed to the lab
Positive results → follow-up colonoscopy recommended

EFFECTIVENESS AND CONSIDERATIONS FIT-DNA detects more cancers and adenomas than
FIT alone
Slightly higher false-positive rate
Both tests are noninvasive and home-based
Selection depends on patient preference, risk
level, and provider advice

https://corum.com.my/education/